# Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy

> **NCT03909464** · — · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 26 (actual)

## Conditions studied

- Cancer
- Malignancy
- Malignant Neoplasm
- Neuropathy
- Neuropathies Sensory
- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DEVICE:** Neurosensory testing with Pressure-Specified Sensory Device

## Key facts

- **NCT ID:** NCT03909464
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2019-11-25
- **Final completion:** 2019-11-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-11-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909464, "Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03909464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*